Antimicrobial resistance of bacterial pathogens isolated from cancer patients: a systematic review and meta-analysis

  05 March 2025

Antimicrobial resistance (AMR) poses a significant threat to global public health, particularly for cancer patients. A comprehensive review of bacterial pathogens isolated from cancer patients revealed a high prevalence of AMR. The most common pathogens were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterococcus faecium, Streptococcus pneumoniae, and Enterobacter spp. The study highlights the urgent need for improved infection prevention and antimicrobial stewardship in cancer care, particularly among ESKAPE pathogens.

Further reading: BMC Infectious Diseases
Author(s): Onyansaniba Kweku Ntim et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!